PMC:7319919 / 6687-6874 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T68","span":{"begin":90,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"d.\n\nDeclaration of Competing Interest\nDavid Bernal-Bello is the principal investigator of a non-sponsored randomized trial assessing the therapeutic role of lopinavir/ritonavir, imatinib,"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52","span":{"begin":157,"end":176},"obj":"Chemical"},{"id":"T53","span":{"begin":157,"end":166},"obj":"Chemical"},{"id":"T54","span":{"begin":167,"end":176},"obj":"Chemical"},{"id":"T55","span":{"begin":178,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_45783"}],"text":"d.\n\nDeclaration of Competing Interest\nDavid Bernal-Bello is the principal investigator of a non-sponsored randomized trial assessing the therapeutic role of lopinavir/ritonavir, imatinib,"}

{"project":"LitCovid-PubTator","denotations":[{"id":"168","span":{"begin":157,"end":176},"obj":"Chemical"},{"id":"169","span":{"begin":178,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A168","pred":"tao:has_database_id","subj":"168","obj":"MESH:C558899"},{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"MESH:D000068877"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d.\n\nDeclaration of Competing Interest\nDavid Bernal-Bello is the principal investigator of a non-sponsored randomized trial assessing the therapeutic role of lopinavir/ritonavir, imatinib,"}

{"project":"LitCovid-sentences","denotations":[{"id":"T51","span":{"begin":4,"end":37},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d.\n\nDeclaration of Competing Interest\nDavid Bernal-Bello is the principal investigator of a non-sponsored randomized trial assessing the therapeutic role of lopinavir/ritonavir, imatinib,"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T94","span":{"begin":157,"end":166},"obj":"DG_23"},{"id":"T95","span":{"begin":167,"end":176},"obj":"DG_30"},{"id":"T96","span":{"begin":178,"end":186},"obj":"CHEBI:14434;CHEBI:14434"},{"id":"T99569","span":{"begin":157,"end":166},"obj":"DG_23"},{"id":"T38180","span":{"begin":167,"end":176},"obj":"DG_30"},{"id":"T67623","span":{"begin":178,"end":186},"obj":"CHEBI:14434;CHEBI:14434"}],"text":"d.\n\nDeclaration of Competing Interest\nDavid Bernal-Bello is the principal investigator of a non-sponsored randomized trial assessing the therapeutic role of lopinavir/ritonavir, imatinib,"}